- Home
- UWMC vs SPRY Comparison
UWMC vs SPRY Comparison
Compare UWMC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UWMC
- SPRY
- Stock Information
- Founded
- UWMC 1986
- SPRY 2015
- Country
- UWMC United States
- SPRY United States
- Employees
- UWMC N/A
- SPRY N/A
- Industry
- UWMC Finance: Consumer Services
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- UWMC Finance
- SPRY Health Care
- Exchange
- UWMC Nasdaq
- SPRY Nasdaq
- Market Cap
- UWMC 1.4B
- SPRY 1.1B
- IPO Year
- UWMC N/A
- SPRY N/A
- Fundamental
- Price
- UWMC $5.64
- SPRY $8.98
- Analyst Decision
- UWMC Hold
- SPRY Strong Buy
- Analyst Count
- UWMC 8
- SPRY 4
- Target Price
- UWMC $6.46
- SPRY $31.25
- AVG Volume (30 Days)
- UWMC 9.2M
- SPRY 1.9M
- Earning Date
- UWMC 11-06-2025
- SPRY 11-11-2025
- Dividend Yield
- UWMC 7.09%
- SPRY N/A
- EPS Growth
- UWMC 112.84
- SPRY N/A
- EPS
- UWMC 0.07
- SPRY N/A
- Revenue
- UWMC $2,622,828,000.00
- SPRY $112,339,000.00
- Revenue This Year
- UWMC $11.44
- SPRY N/A
- Revenue Next Year
- UWMC $12.48
- SPRY $193.13
- P/E Ratio
- UWMC $85.09
- SPRY N/A
- Revenue Growth
- UWMC 13.45
- SPRY 22367.80
- 52 Week Low
- UWMC $3.80
- SPRY $8.90
- 52 Week High
- UWMC $7.14
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- UWMC 46.50
- SPRY 33.53
- Support Level
- UWMC $5.19
- SPRY $9.08
- Resistance Level
- UWMC $5.95
- SPRY $10.38
- Average True Range (ATR)
- UWMC 0.20
- SPRY 0.52
- MACD
- UWMC 0.04
- SPRY -0.08
- Stochastic Oscillator
- UWMC 60.00
- SPRY 2.86
About UWMC UWM Holdings Corporation
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.